These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37989489)

  • 21. Beta-blocker use and acute exacerbations of COPD following myocardial infarction: a Danish nationwide cohort study.
    Rasmussen DB; Bodtger U; Lamberts M; Torp-Pedersen C; Gislason G; Lange P; Jensen MT
    Thorax; 2020 Nov; 75(11):928-933. PubMed ID: 32820080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease.
    Zvizdic F; Begic E; Mujakovic A; Hodzic E; Prnjavorac B; Bedak O; Custovic F; Bradaric H; Durak-Nalbantic A
    Med Arch; 2019 Apr; 73(2):72-75. PubMed ID: 31391690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry study.
    Huang B; Yang Y; Zhu J; Liang Y; Zhang H; Tian L; Shao X; Wang J
    J Am Med Dir Assoc; 2014 Aug; 15(8):576-81. PubMed ID: 24894999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
    Durheim MT; Holmes DN; Blanco RG; Allen LA; Chan PS; Freeman JV; Fonarow GC; Go AS; Hylek EM; Mahaffey KW; Pokorney SD; Reiffel JA; Singer DE; Peterson ED; Piccini JP
    Heart; 2018 Nov; 104(22):1850-1858. PubMed ID: 29875139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
    Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin prescription in patients with chronic obstructive pulmonary disease and risk of exacerbations: a retrospective cohort study in the Clinical Practice Research Datalink.
    Smith MC; Ashdown HF; Sheppard JP; Butler CC; Bankhead C
    BMJ Open; 2021 Dec; 11(12):e050757. PubMed ID: 34876426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic obstructive pulmonary disease in patients with atrial fibrillation: Insights from the ARISTOTLE trial.
    Durheim MT; Cyr DD; Lopes RD; Thomas LE; Tsuang WM; Gersh BJ; Held C; Wallentin L; Granger CB; Palmer SM; Al-Khatib SM
    Int J Cardiol; 2016 Jan; 202():589-94. PubMed ID: 26447668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
    Neef PA; Burrell LM; McDonald CF; Irving LB; Johnson DF; Steinfort DP
    Intern Med J; 2017 Sep; 47(9):1043-1050. PubMed ID: 28608512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations.
    Lin CM; Yang TM; Yang YH; Tsai YH; Lee CP; Chen PC; Chen WC; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2020; 15():289-299. PubMed ID: 32103928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study.
    Yeh JJ; Wei YF; Lin CL; Hsu WH
    BMJ Open; 2017 Oct; 7(10):e017657. PubMed ID: 28982831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detrimental Impact of Chronic Obstructive Pulmonary Disease in Atrial Fibrillation: New Insights from Umbria Atrial Fibrillation Registry.
    Angeli F; Reboldi G; Trapasso M; Aita A; Ambrosio G; Verdecchia P
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31324041
    [No Abstract]   [Full Text] [Related]  

  • 34. A prospective study of the clinical outcomes and prognosis associated with comorbid COPD in the atrial fibrillation population.
    Rodríguez-Mañero M; López-Pardo E; Cordero A; Ruano-Ravina A; Novo-Platas J; Pereira-Vázquez M; Martínez-Gómez Á; García-Seara J; Martínez-Sande JL; Peña-Gil C; Mazón P; García-Acuña JM; Valdés-Cuadrado L; González-Juanatey JR
    Int J Chron Obstruct Pulmon Dis; 2019; 14():371-380. PubMed ID: 30863038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
    Du Q; Sun Y; Ding N; Lu L; Chen Y
    PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

  • 37. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.
    Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK
    Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicentric study on the beta-blocker use and relation with exacerbations in COPD.
    Puente-Maestu L; Calle M; Ortega-González A; Fuster A; González C; Márquez-Martín E; Marcos-Rodriguez PJ; Calero C; Rodríguez-Hermosa JL; Malo de Molina R; Aburto M; Sobradillo P; Alcázar B; Tirado-Conde G;
    Respir Med; 2014 May; 108(5):737-44. PubMed ID: 24635914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist.
    Yang HH; Lai CC; Wang YH; Yang WC; Wang CY; Wang HC; Chen L; Yu CJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2477-2485. PubMed ID: 28860742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Competitive interaction between chronic obstructive pulmonary disease and CHA
    Perticone M; Sciacqua A; Tripepi G; Miceli S; Corrao S; Sesti G; Perticone F
    Int J Cardiol; 2018 Mar; 255():74-79. PubMed ID: 29174184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.